Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.
Press releases published on September 9, 2025
CHAPPER healthcare, AscellaHealth’s Global Pharmaceutical Distributor, Assumes Presidency of EUROPACCESS, Enhancing Access to Innovative Medicines
GlobeNewswire
·
September 9, 2025
WATFORD, United Kingdom and BERWYN, Pa., Sept. 09, 2025 (GLOBE NEWSWIRE) -- CHAPPER healthcare, AscellaHealth’s global pharmaceutical wholesaler, distributor and commercialization service provider, announces its appointment as president of EUROPACCESS, a …
Biosplice Therapeutics Announces First Patient Dosed in NCI-Sponsored Clinical Trial of Cirtuvivint in Acute Myeloid Leukemia and Myelodysplastic Syndromes
GlobeNewswire
·
September 9, 2025
SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering advancements in small molecule inhibition of CDC-like kinases (CLK) and Dual-specificity tyrosine phosphorylation- …
Persephone Biosciences Unveils First-Of-Its-Kind Synbiotic Designed To Restore Critical Gut Microbes In Babies
GlobeNewswire
·
September 9, 2025
Newly released data shows that nine in ten babies lack critical gut microbes needed for healthy development. Persephone’s Daily Synergistic Synbiotic, built on the largest and most comprehensive U.S. infant gut microbiome study, can help restore them. In …
Rarecells Announces New Clinical Data Showing Superior Sensitivity and Tumor Heterogeneity Detection by Synergistic Combination of ctDNA and ISET® CTC-DNA in Patients with Early-Stage Lung Cancer
GlobeNewswire
·
September 9, 2025
NEW YORK and PARIS, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Rarecells, a pioneer in liquid biopsy technologies, today presented new data (poster EP.06.64) at the IASLC 2025 World Conference on Lung Cancer (WCLC) in Barcelona, Spain, from its BioMolCTC Trial …
Scenic Biotech Appoints Dr. Roland W. Bürli as CSO to Advance Pipeline of Modifier Therapies in Neuro- and Metabolic Diseases
GlobeNewswire
·
September 9, 2025
Scenic Biotech taps Dr. Bürli as Chief Scientific Officer to lead development of innovative drug candidate pipeline fueled by the company’s Cell-Seq platform. Amsterdam, the Netherlands, September 09, 2025 – Scenic Biotech, a pioneer in the field of …
Reaktor and ZAP Surgical win renowned Red Dot Award for ZAP-AXON, a next-generation treatment planning system for brain radiosurgery
GlobeNewswire
·
September 9, 2025
Helsinki, Finland, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Reaktor and ZAP Surgical’s joint redesign of the next-generation ZAP-AXON® Radiosurgery Planning System (RPS) has won the prestigious Red Dot Award in the Brands …
Tourmaline Bio Enters into Agreement to be Acquired by Novartis AG
GlobeNewswire
·
September 9, 2025
– Novartis to acquire Tourmaline Bio for $48.00 per share in cash for a total equity value of approximately $1.4 billion – – Transaction reflects the potential of Tourmaline’s pacibekitug, a long-acting, fully-human, anti-IL-6 monoclonal antibody with best …
Amgen and Kyowa Kirin Announce Top-Line Results From Rocatinlimab Phase 3 ASCEND Long-Term Extension Study in Adults With Moderate to Severe Atopic Dermatitis
GlobeNewswire
·
September 9, 2025
THOUSAND OAKS, Calif. and TOKYO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Amgen (NASDAQ:AMGN) and Kyowa Kirin Co., Ltd. (TSE:4151) today announced preliminary top-line results from the ASCEND study evaluating rocatinlimab, an investigational T-cell rebalancing …
Valley Wellness to open luxury behavioral health facility in Corona, CA
GlobeNewswire
·
September 9, 2025
CORONA, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Valley Wellness, a California-based behavioral health treatment company, has announced the opening of its first facility in Corona, CA. The company has selected a 4.2-acre estate in Corona Hills, and work …